Janet Woodcock and Francis Collins (FDA/NIH)
Covid-19 roundup: FDA and NIH leaders continue sharing lessons from the pandemic; Slovenia halts J&J vaccine rollout to investigate death — report
Back in March, FDA acting commissioner Janet Woodcock and NIH director Francis Collins began the long, slow process of explaining some of the lessons they’ve learned since the start of the Covid-19 pandemic — ranging from the lack of research infrastructure to the importance of partnerships with industry.
Yesterday, they went into round 2 on what needs to change in preparation for the next pandemic, pointing to the White House’s $65 billion Pandemic Preparedness Plan.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
